Enter your login e-mail to the account
Search
- The first symptoms of multiple sclerosis and the importance of early treatment
Doc. MUDr. Vladimír Donáth, PhD.
(5/2017, Interdisciplinary consilium ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium )
- Intrathecal synthesis of specific antiviral antibodies in relapsing-remitting and primary chronic progressive courses of multiple sclerosis
doc. MUDr. Pavel Štourač, Ph.D., MUDr. Jana Bednářová, Ph.D.
(5/2009, Main topic ) - Laboratory biomarkers of multiple sclerosis
MUDr. Kamila Žondra Revendová, Ph.D., MUDr. Ing. David Zeman, Ph.D., MUDr. Radovan Bunganič, MUDr. Kryštof Damián Švub, MUDr. Ondřej Pelíšek, doc. RNDr. Pavlína Kušnierová, Ph.D.
(1/2026, Main topic ) - Early diagnosis and treatment of multiple sclerosis
MUDr. Marek Peterka , MUDr. Pavel Potužník
(2/2021, Review articles ) - Errors and mistakes in diagnosing multiple sclerosis
MUDr. Jiří Piťha
(3/2015, Review articles ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - Current options in the treatment of multiple sclerosis
MUDr. Eva Meluzínová
(5/2010, Review articles ) - Anti-NMDAr-panecefalitida – klinická kazuistika
MUDr. Michaela Tomečková, MUDr. Ondřej Horák, doc. MUDr. Hana Ošlejšková, Ph.D.
(2/2018, Case reports ) - Glatiramer acetate and treatment of multiple sclerosis
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová, MUDr. Ludovít Hofmann Klzo, Ph.D.
(4/2015, Case reports ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis
MUDr. Marek Peterka
(6/2022, Review articles ) - Neuromyelitis optica (Devic's disease) – first demyelinating aquaporin channelopathy?
doc. MUDr. Eva Havrdová, CSc., MUDr. Dana Horáková, prof. MUDr. Zdeněk Seidl, CSc., MUDr. Petra Nytrová, RNDr. Vlastimil Král, CSc., doc. MUDr. Manuela Vaněčková, Ph.D.
(1/2010, Review articles ) - Klinicky izolovaný syndrom a prognostické markery u roztroušené sklerózy. Proč léčit včas?
MUDr. Dana Horáková
(4/2008, Main topic ) - Léčba spondylogenní cervikální myelopatie – standard či problém?
prof. MUDr. Zdeněk Kadaňka, doc. MUDr. Josef Bednařík, CSc., MUDr. Miroslav Mareš, doc. MUDr. Vladimír Smrčka CSc.
(1/2002, Main topic )












